HK1066222A1 - Mannitol and glucitol derivatives - Google Patents

Mannitol and glucitol derivatives

Info

Publication number
HK1066222A1
HK1066222A1 HK04109223.6A HK04109223A HK1066222A1 HK 1066222 A1 HK1066222 A1 HK 1066222A1 HK 04109223 A HK04109223 A HK 04109223A HK 1066222 A1 HK1066222 A1 HK 1066222A1
Authority
HK
Hong Kong
Prior art keywords
mannitol
glucitol derivatives
oligomeric compounds
glucitol
derivatives
Prior art date
Application number
HK04109223.6A
Other languages
English (en)
Inventor
Frank Bergmann
Der Eltz Herbert Von
Christoph Seidel
Kurt Weindel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP02028714A external-priority patent/EP1431297A1/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1066222A1 publication Critical patent/HK1066222A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
HK04109223.6A 2002-12-20 2004-11-22 Mannitol and glucitol derivatives HK1066222A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02028714A EP1431297A1 (de) 2002-12-20 2002-12-20 Mannitol- und Glucitolderivate
US44021203P 2003-01-15 2003-01-15
EP03001215 2003-01-20

Publications (1)

Publication Number Publication Date
HK1066222A1 true HK1066222A1 (en) 2005-03-18

Family

ID=32600614

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04109223.6A HK1066222A1 (en) 2002-12-20 2004-11-22 Mannitol and glucitol derivatives

Country Status (8)

Country Link
EP (1) EP1431298B1 (de)
JP (1) JP4169689B2 (de)
CN (1) CN1513849B (de)
AT (1) ATE319699T1 (de)
CA (1) CA2453382C (de)
DE (1) DE60303865T2 (de)
ES (1) ES2260569T3 (de)
HK (1) HK1066222A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2370450A1 (de) 2008-11-27 2011-10-05 Roche Diagnostics GmbH Gezielte synthese von oligophosphoramidatstereoisomeren
AU2010296018B2 (en) 2009-09-16 2016-05-05 Genentech, Inc. Coiled coil and/or tether containing protein complexes and uses thereof
AR080793A1 (es) 2010-03-26 2012-05-09 Roche Glycart Ag Anticuerpos biespecificos
ES2605493T3 (es) 2010-12-23 2017-03-14 F. Hoffmann-La Roche Ag Detección de un polipéptido modificado post-traduccionalmente mediante un agente ligante bivalente
JP6162044B2 (ja) 2010-12-23 2017-07-12 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 結合剤
EP2655413B1 (de) 2010-12-23 2019-01-16 F.Hoffmann-La Roche Ag Polypeptid-polynukleotid-komplex und verwendung bei der gezielten effektorrest-bereitstellung
BR112014019579A2 (pt) 2012-02-10 2019-10-15 Genentech, Inc Anticorpo de cadeia única, polinucleotídeo, vetor, célula hospedeira, método de produção de um anticorpo de cadeia única, heteromultímero e método de produção do heteromultímero
WO2014001324A1 (en) 2012-06-27 2014-01-03 Hoffmann-La Roche Ag Method for selection and production of tailor-made highly selective and multi-specific targeting entities containing at least two different binding entities and uses thereof
EP2867254B1 (de) 2012-06-27 2017-10-25 F. Hoffmann-La Roche AG Verfahren zum herstellen von antikörper-fc-region-konjugaten mit mindestens einer bindungsstelle, die spezifisch an ein target bindet, und verwendungen davon
WO2016087416A1 (en) 2014-12-03 2016-06-09 F. Hoffmann-La Roche Ag Multispecific antibodies
WO2018013999A1 (en) 2016-07-15 2018-01-18 Am Chemicals Llc Non-nucleosidic solid supports and phosphoramidite building blocks for oligonucleotide synthesis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000505778A (ja) * 1994-08-17 2000-05-16 スティヒティング・レガ・ヴェー・ゼット・ウェー 核酸に関する配列特異的結合性オリゴマーおよびアンチセンスストラテジーにおけるそれらの用途
DE10044373A1 (de) * 2000-09-08 2002-03-21 Roche Diagnostics Gmbh Neues Reagenz zur Markierung von Nukleinsäuren

Also Published As

Publication number Publication date
CN1513849B (zh) 2013-03-27
DE60303865T2 (de) 2006-09-21
DE60303865D1 (de) 2006-05-04
EP1431298A1 (de) 2004-06-23
JP4169689B2 (ja) 2008-10-22
CN1513849A (zh) 2004-07-21
ATE319699T1 (de) 2006-03-15
JP2004203878A (ja) 2004-07-22
ES2260569T3 (es) 2006-11-01
EP1431298B1 (de) 2006-03-08
CA2453382C (en) 2009-04-07
CA2453382A1 (en) 2004-06-20

Similar Documents

Publication Publication Date Title
HK1054967A1 (en) Method of amplifying nucleic acid by using double-stranded nucleic acid as template
HK1052030A1 (en) A method for the determination of a nucleic acid using a control
WO2003004614A3 (en) Identification and use of conserved noncoding sequences
DE60041072D1 (de) Em nachweis
WO2005044836A3 (de) Makromolekulare nukleotidverbindungen und methoden zu deren anwendung
NO20044290L (no) Fremgangsmate for forbedring av boredybdemalinger
DE50113023D1 (de) Verfahren zur Konditionierung von organischen Pigmenten
DE502004010433D1 (de) Prozeß zur Herstellung von Aryl- oder Heteroarylamin-Boronsäurederivaten
ATE381552T1 (de) Derivate von 1-piperazin- und 1- homopiperazincarboxylaten, verfahren zu deren herstellung und deren verwendung als inhibitoren des faah-enzyms
EP1516053A4 (de) Xylanasen, diese codierende nukleinsäuren sowie verfahren zur herstellung und verwendung davon
DK1831362T3 (da) Syreaktive svampeproteaser
WO2005087951A3 (en) Reagents, methods and kits for use in deactivating nucleic acids
HK1066222A1 (en) Mannitol and glucitol derivatives
DE60235005D1 (de) Nachweis der instabilität von mikrosatelliten und
DE60307710D1 (de) Verfahren zur Herstellung von Eisenoxiden
DE60132924D1 (de) Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2)
DE602005014280D1 (de) Verfahren zur herstellung von ä1,4,5ü-oxadiazepinderivaten
WO2003097810A3 (en) Nitrilases, nucleic acids encoding them and methods for making and using them
WO2003048309A3 (en) Thermus thermophilus nucleic acid polymerases
AU2003250506A8 (en) Method for the characteristation of nucleic acid molecules
DE502004009152D1 (de) Verfahren zur herstellung von derivaten des 4a,5,9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
NO20043926L (no) Mikroorganismer som baerere av nukleotidsekvenser kodede for celleantigener anvendt ved behandling av tumorer
WO2004029283A3 (en) Subtelomeric dna probes and method of producing the same
DE60335766D1 (de) Verfahren zur Herstellung von m-Xylylendiamin
IT1319242B1 (it) Processo per la preparazione di maleato di fluvossamina.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20181219